The Trans-Pacific Partnership Agreement, Intellectual Property and Medicines: Differential Outcomes for Developed and Developing Countries
Ever since the Agreement on Trade-Related Aspects of Intellectual Property (TRIPS) set a new global benchmark for intellectual property (IP) rights in the 1990s, civil society groups have raised concerns about the impact of trade agreements on access to medicines. One such trade agreement, the Trans-Pacific Partnership Agreement (TPP), was a proposed regional trade agreement […]